Drug-target network
- PMID: 17921997
- DOI: 10.1038/nbt1338
Drug-target network
Abstract
The global set of relationships between protein targets of all drugs and all disease-gene products in the human protein-protein interaction or 'interactome' network remains uncharacterized. We built a bipartite graph composed of US Food and Drug Administration-approved drugs and proteins linked by drug-target binary associations. The resulting network connects most drugs into a highly interlinked giant component, with strong local clustering of drugs of similar types according to Anatomical Therapeutic Chemical classification. Topological analyses of this network quantitatively showed an overabundance of 'follow-on' drugs, that is, drugs that target already targeted proteins. By including drugs currently under investigation, we identified a trend toward more functionally diverse targets improving polypharmacology. To analyze the relationships between drug targets and disease-gene products, we measured the shortest distance between both sets of proteins in current models of the human interactome network. Significant differences in distance were found between etiological and palliative drugs. A recent trend toward more rational drug design was observed.
Comment in
-
Network pharmacology.Nat Biotechnol. 2007 Oct;25(10):1110-1. doi: 10.1038/nbt1007-1110. Nat Biotechnol. 2007. PMID: 17921993 No abstract available.
Similar articles
-
Network pharmacology.Nat Biotechnol. 2007 Oct;25(10):1110-1. doi: 10.1038/nbt1007-1110. Nat Biotechnol. 2007. PMID: 17921993 No abstract available.
-
Interaction networks: from protein functions to drug discovery. A review.Pathol Biol (Paris). 2009 Jun;57(4):324-33. doi: 10.1016/j.patbio.2008.10.004. Epub 2008 Dec 13. Pathol Biol (Paris). 2009. PMID: 19070972 Review.
-
Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods.Artif Intell Med. 2010 Feb-Mar;48(2-3):161-6. doi: 10.1016/j.artmed.2009.11.002. Epub 2009 Dec 3. Artif Intell Med. 2010. PMID: 19962282
-
The topology of drug-target interaction networks: implicit dependence on drug properties and target families.Mol Biosyst. 2009 Sep;5(9):1051-7. doi: 10.1039/b905821b. Epub 2009 Jul 8. Mol Biosyst. 2009. PMID: 19668871
-
Trends in exploration of therapeutic targets.Drug News Perspect. 2005 Mar;18(2):109-27. doi: 10.1358/dnp.2005.18.2.886480. Drug News Perspect. 2005. PMID: 15883620 Review.
Cited by
-
Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.BMC Genomics. 2015;16 Suppl 7(Suppl 7):S8. doi: 10.1186/1471-2164-16-S7-S8. Epub 2015 Jun 11. BMC Genomics. 2015. PMID: 26099335 Free PMC article.
-
Ophidiomycosis surveillance of snakes in Georgia, USA reveals new host species and taxonomic associations with disease.Sci Rep. 2020 Jul 2;10(1):10870. doi: 10.1038/s41598-020-67800-1. Sci Rep. 2020. PMID: 32616837 Free PMC article.
-
A functional variomics tool for discovering drug-resistance genes and drug targets.Cell Rep. 2013 Feb 21;3(2):577-85. doi: 10.1016/j.celrep.2013.01.019. Epub 2013 Feb 14. Cell Rep. 2013. PMID: 23416056 Free PMC article.
-
DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.BMC Bioinformatics. 2016 May 5;17(1):202. doi: 10.1186/s12859-016-1065-y. BMC Bioinformatics. 2016. PMID: 27151405 Free PMC article.
-
Molecular network-based analysis of guizhi-shaoyao-zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy.Acta Pharmacol Sin. 2015 Jun;36(6):716-23. doi: 10.1038/aps.2015.15. Epub 2015 Apr 27. Acta Pharmacol Sin. 2015. PMID: 25948477 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
